Questioning the 1.5 billion dollar vaccine deal

Opinion April 25, 2008

Médecins Sans Frontières does not deny the rationale of the Advance Market Commitment: a new vaccine against pneumococcal disease is desperately needed. Over a million people, mostly children, die each year of pneumonia, bloodstream infections and meningitis caused by pneumococcal bacteria. But why is it so expensive?

Tido von Schoenangerer, Director of Campaign for Essential Medicines at MSF.
Photo by Sebastian Bolesch

If you are new to Development Today and would like to continue reading this article, send us a mail at subscribers@devtoday.no, including your name, title, organisation, and email contact, and you will receive a free Guest Pass, along with weekly updates.

Questioning the 1.5 billion dollar vaccine deal

Tags: